病理T3期非小细胞肺癌手术切除的完整性与长期生存:国际肺癌研究协会分析
基于国际肺癌研究协会1999至2010年数据库,纳入1448例病理T3N0M0非小细胞肺癌患者,分析不同T3描述词下手术切除完整性与总生存。胸壁侵犯或壁层胸膜侵犯者不完全切除率最高(分别为9.8%和8.4%),仅按大小分类者最低(2.9%);不同T3描述词间总生存差异有统计学意义(p=0.005)。按大小或同叶卫星结节分类者5年总生存优于壁层胸膜侵犯或胸壁侵犯者(60% vs 53%,p=0.017)。
要点
- 胸壁侵犯或壁层胸膜侵犯的T3肿瘤不完全切除率最高,分别为9.8%和8.4%。
- 仅按大小分类的T3肿瘤不完全切除率最低,为2.9%。
- 按大小或同叶卫星结节分类者5年总生存60%,优于壁层胸膜侵犯或胸壁侵犯者的53%(p=0.017)。
核心结论
- 按大小、同叶卫星结节、壁层胸膜侵犯或胸壁侵犯定义的T3描述词与5年总生存差异相关。
- 根据有无胸壁侵犯或壁层胸膜侵犯细分病理T3N0M0肿瘤可能提高肿瘤分期的预后准确性。
研究设计与样本
- 国际肺癌研究协会1999至2010年数据库分析,纳入接受肺叶切除或全肺切除的病理T3N0M0非小细胞肺癌患者1448例。
- 主要结局为按T3描述词和切除完整性分层的总生存。
主要发现
- 1448例T3N0M0肿瘤中,1187例(82.0%)由单一描述词定义为T3。
- 胸壁侵犯和壁层胸膜侵犯肿瘤的不完全切除率分别为9.8%和8.4%,仅按大小分类者为2.9%。
- 不同T3描述词间总生存差异有统计学意义(p=0.005)。
- 按大小或同叶卫星结节分类者5年总生存60%,优于壁层胸膜侵犯或胸壁侵犯者的53%(p=0.017),且独立于切除完整性。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Currently, tumors with different histopathologic characteristics and oncologic outcomes comprise the T3 category of the eight edition TNM classification for lung cancers. To better understand the T3 category, we evaluated completeness of resection and long-term survival in patients undergoing resection for T3 NSCLC. METHODS: The International Association for the Study of Lung Cancer 1999 to 2010 database was queried for patients with pathologic T3N0M0 NSCLC who underwent lobectomy or pneumonectomy. The primary outcome evaluated was overall survival (OS) stratified by T3 descriptors and completeness of resection. RESULTS: Of 1448 patients with T3N0M0 tumors, 1187 (82.0%) had a single descriptor defining them as T3. T3 tumors with chest wall infiltration (CWI) or parietal pleura infiltration (PL3) had the highest rates of incomplete resection (9.8% and 8.4%, respectively), and those classified as T3 by size only had the lowest rate of incomplete resection (2.9%). Individual T3 descriptors were associated with significant differences in OS (p = 0.005). When tumors with similar survival and complete resection rates were grouped, patients with T3 tumors characterized by size or the presence of a separate nodule (SN) in the same lobe had better 5-year OS than patients with tumors characterized by PL3 or CWI (size/SN 60% versus CWI/PL3 53%, p = 0.017) independent of completeness of resection. CONCLUSIONS: Significant differences in 5-year OS were associated with size, SN, PL3, or CWI T3 descriptors. Subdividing pathologic T3N0M0 tumors according to the presence or absence of CWI or PL3 may increase the prognostic accuracy of tumor staging.
引用
- Ugalde Figueroa PA, Marques E, Cilento VJ, et al. Completeness of Resection and Long-Term Survival of Patients Undergoing Resection for Pathologic T3 NSCLC: An International Association for the Study of Lung Cancer Analysis. J Thorac Oncol. 2023. PMID: 37717854. doi:10.1016/j.jtho.2023.09.277
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。